Elanco Animal Health Inc
NYSE:ELAN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Elanco Animal Health Inc
NYSE:ELAN
|
US |
|
Telefonaktiebolaget LM Ericsson
STO:ERIC B
|
SE |
|
Ocugen Inc
NASDAQ:OCGN
|
US |
|
SoftBank Corp
TSE:9434
|
JP |
|
Sociedad Quimica y Minera de Chile SA
NYSE:SQM
|
CL |
|
British American Tobacco PLC
LSE:BATS
|
UK |
|
Ezenia! Inc
OTC:EZEN
|
US |
|
Sturm Ruger & Company Inc
NYSE:RGR
|
US |
|
J
|
Jacobson Pharma Corporation Ltd
HKEX:2633
|
HK |
|
Manulife Financial Corp
TSX:MFC
|
CA |
|
Sonoco Products Co
NYSE:SON
|
US |
|
SeaWorld Entertainment Inc
NYSE:PRKS
|
US |
|
Hain Celestial Group Inc
NASDAQ:HAIN
|
US |
|
Auckland International Airport Ltd
NZX:AIA
|
NZ |
|
Galaxy Entertainment Group Ltd
HKEX:27
|
HK |
|
Fortress Biotech Inc
NASDAQ:FBIO
|
US |
|
A-Living Smart City Services Co Ltd
F:1V0
|
CN |
|
P
|
Pasifik Eurasia Lojistik Dis Ticaret AS
IST:PASEU.E
|
TR |
|
Sekisui Chemical Co Ltd
TSE:4204
|
JP |
|
BrainPad Inc
TSE:3655
|
JP |
|
Chemung Financial Corp
NASDAQ:CHMG
|
US |
|
Escorts Kubota Ltd
NSE:ESCORTS
|
IN |
|
M
|
Megawide Construction Corp
XPHS:MWIDE
|
PH |
|
Star Entertainment Group Ltd
ASX:SGR
|
AU |
Wall St Price Targets
ELAN Price Targets Summary
Elanco Animal Health Inc
According to Wall Street analysts, the average 1-year price target for ELAN is 30.6 USD with a low forecast of 24.24 USD and a high forecast of 33.6 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ELAN's stock price target?
Price Target
30.6
USD
According to Wall Street analysts, the average 1-year price target for ELAN is 30.6 USD with a low forecast of 24.24 USD and a high forecast of 33.6 USD.
What is the Revenue forecast for Elanco Animal Health Inc?
Projected CAGR
4%
Over the last 11 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is 4%.
What is the Operating Income forecast for Elanco Animal Health Inc?
Projected CAGR
23%
Over the last 11 years, the compound annual growth rate for Operating Income has been -2%. The projected CAGR for the next 8 years is 23%.
